FDA Inspection
Rosemont Pharmaceuticals Ltd.Rosemont Pharmaceuticals Ltd. – FDA Inspection, Dec 12, 2014
Record Details
This FDA Inspection record concerns Rosemont Pharmaceuticals Ltd., with an inspection on December 12, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 12, 2014
- Product Type
- Drugs
View Company Profile
ID · 1201486e-97d0-4ba1-a281-e682d708d41b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 906518
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rosemont Pharmaceuticals Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Office of Inspections and Investigations | |
| February 8, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rosemont Pharmaceuticals Ltd.
- FDA Inspection 1320962 - 2026-04-24
- FDA Inspection 1113598 - 2019-02-08
- FDA Inspection 753983 - 2011-10-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.